0.5640SEK-12.42%Mkt Cap: 185.43M SEKP/E: 1.94Last update: 2026-06-01
Nanologica AB (publ), a life science tools company, develops, manufactures, and sells nanoporous silica particles in China, India, Turkey, the United States, and internationally. The company offers NLAB Saga, a silica-ba…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap185.43M SEK
Enterprise Value157.08M SEK
Revenue (TTM)31.83M SEK
Gross Profit4.30M SEK
Net Income (TTM)-51.29M SEK
Revenue/Share0.3440 SEK
Last Price0.5640 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees72
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0005454873
Valuation
P/E (Trailing)1.94
P/E (Forward)2.22
PEG—
EV/EBITDA-3.43
EV/Revenue4.93
P/S6.65
P/B0.79
EPS (TTM)0.29
EPS (Forward)0.29
52W Range
0.330012% of range2.250
52W High2.250 SEK
52W Low0.3300 SEK
Profitability
Gross Margin20.33%
Oper. Margin-50.95%
EBITDA Margin-143.76%
Profit Margin-242.77%
ROE-226.49%
ROA-58.21%
Growth
Revenue Growth99.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-39.83M SEK
CapEx (TTM)1.08M SEK
FCF Margin-39.08%
FCF Yield-6.71%
Net Debt79.81M SEK
Net Debt/EBITDA-1.74
Balance Sheet
Debt/Equity0.95
Current Ratio1.15
Quick Ratio0.53
Book Value/Sh0.8130 SEK
Cash/Share0.3270 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)1.700 SEK
Target Range1.700 SEK – 1.700 SEK
# Analysts1
Ownership
Shares Out.328.77M
Float89.26M
Insiders36.85%
Institutions42.28%
Technical
SMA 500.5329 (+5.8%)
SMA 2000.7964 (-29.2%)
Beta-0.12
S&P 52W Chg27.70%
Avg Vol (30d)8.64M
Avg Vol (10d)10.20M
Technical Indicators
RSI (14)53.0
MACD0.0415
MACD Signal0.0299
MACD Hist.+0.0116
BB Upper0.7784 SEK
BB Middle0.5734 SEK
BB Lower0.3683 SEK
BB Width71.52%
ATR (14)0.1265 SEK
Vol Ratio (20d)0.60x